NASDAQ: BBNX · Industrial Applications and Services · 9 alerts · CIK 1674632
Share price
$15.21Close, Nov 16
Market cap
$827M
Shares outstanding
54.37MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Beta Bionics, Inc. filings on SEC EDGAR ↗
Beta Bionics CFO Stephen Feider Sells $153K of Stock
Stephen Feider, CFO, sold 8,874 shares of Beta Bionics, Inc. at $17.21 a share, worth $153K in total on Nov 11, 2026. Shares held after the trade: 159,378 (-5.3%).
Beta Bionics CFO Stephen Feider Sells $12.6K of Stock
Stephen Feider, CFO, sold 744 shares of Beta Bionics, Inc. at $17.00 a share, worth $12.6K in total on Nov 9, 2026. Shares held after the trade: 159,378 (-0.5%).
Beta Bionics Chief Product Officer Mike Mensinger Sells $58.3K of Stock
Mike Mensinger, Chief Product Officer, sold 2,650 shares of Beta Bionics, Inc. at $22.00 a share, worth $58.3K in total on Oct 27, 2026. Shares held after the trade: 174,740 (-1.5%).
Beta Bionics Chief Commercial Officer Mark Hopman Sells $16.4K of Stock
Mark Hopman, Chief Commercial Officer, sold 821 shares of Beta Bionics, Inc. at $20.00 a share, worth $16.4K in total on Oct 26, 2026. Shares held after the trade: 54,513 (-1.5%).
Beta Bionics Chief Commercial Officer Mark Hopman Sells $13.4K of Stock
Mark Hopman, Chief Commercial Officer, sold 775 shares of Beta Bionics, Inc. at $17.35 a share, worth $13.4K in total on Oct 14, 2026. Shares held after the trade: 55,334 (-1.4%).